Default Category
-
Nissan Motor Co. Ltd.--2002 (Spanish version)
Yoshino, Michael Y.; Egawa, MasakoCase HBS-304S07StrategyCarlos Ghosn, a former executive vice president of Renault, became the COO of Nissan Motor Co., a troubled auto company in Japan when Renault bought 38% of the company in 1999. This case deals with how Ghosn turned the company around. Examines in considerable detail how he went about successfully energizing and mobilizing the demoralized employees after a decade of failed efforts. Having successfully transformed itself, the company faces a series...Starting at €8.20
-
Implementing the Nissan Renewal Plan (Spanish version)
Yoshino, Michael Y.; Egawa, MasakoCase HBS-305S10StrategyCarlos Ghosn, a former executive vice-president of Renault, became the COO of Nissan Motor Co., a troubled auto company in Japan when Renault bought 38% of the company in 1999. This case deals with how Ghosn turned the company around. Examines in considerable detail how he went about successfully energizing and mobilizing the demoralized employees after a decade of failed efforts. A rewritten version of an earlier case.Starting at €8.20
-
NutraSweet en China (B)
Yoshino, Michael Y.; Knoop, Carin-Isabel; St. George, AnthonyCase HBS-309S30Knowledge and CommunicationComplementa el caso (A).Starting at €5.74
-
Cancer Screening in Japan: Market Research and Segmentation
Quelch, John A.; Rodriguez, MargaretCase HBS-514057-EMarketingSince founding CancerScan in 2008, Jun Fukuyoshi and Yoshiki Ishikawa had helped to improve cancer screening rates in Japan. Between 2005 and 2007, awareness of breast cancer in Japan rose from 55% to 70%, but the incidence of breast cancer screenings remained constant. Jun and Yoshiki applied marketing research techniques to increase the screening rate for breast cancer, a disease which killed over 12,000 Japanese women in 2011. Cancer screening...Starting at €8.20
-
Vision 2020: Takeda and the Vaccine Business
Quelch, John A.; Rodriguez, MargaretCase HBS-514084-EMarketingTo maximize their effectiveness, color cases should be printed in color. In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief executive in 2009. By 2013, Takeda was in the midst of implementing its new Vision 2020 plan, a s...Starting at €8.20
-
TNT Ltd.'s Logistics Services in Asia (A): The Strategy
Yoshino, Michael Y.; Knoop, Carin-IsabelCase HBS-397017-EEconomicsMeredith Hellicar's mission as general manager of corporate development is to make TNT Ltd. one of the biggest and most diverse transport and logistic companies in the world, with approximately $5 billion in turnover in 1993, a leading provider of logistics services in Asia. The case describes the approach she used to rank countries and select China and Thailand as priority markets. She has just presented her recommendation to the board when a ma...Starting at €8.20
-
Renault-Nissan Alliance (Spanish version)
Yoshino, Michael Y.; Fagan, Perry L.Case HBS-304S08StrategyOn Wednesday, May 29, 2002, the board of directors of Renault-Nissan BV (RNBV) met for the first time to discuss the state of the alliance between Renault SA and Nissan Motors-two of the world's largest automakers. RNBV was a 50/50 joint venture company established in March of that year to oversee the strategy of the alliance and all activities undertaken jointly by Renault and Nissan. The new company would "steer alliance strategy and supervise ...Starting at €8.20
-
NutraSweet en China (A)
Yoshino, Michael Y.; Knoop, Carin-IsabelCase HBS-309S29Knowledge and CommunicationEva Stacey, una reciente MBA de Harvard, tiene la difícil tarea de evaluar la oportunidad de mercado para NutraSweet en China. Ella debe decidir la mejor manera de desarrollar el mercado para el producto en China. Se puede utilizar con NutraSweet en China (B).Starting at €8.20
-
GlaxoSmithKline in China (A)
Quelch, John A.; Rodriguez, MargaretCase HBS-514049-EMarketingFour GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to local customs while still observing local laws.Starting at €8.20
-
GlaxoSmithKline in China (B)
Quelch, John A.; Rodriguez, MargaretCase HBS-514050-EMarketingIn 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."Starting at €5.74